[Common variable immune deficiency: what you need to know]

Area of Science:

• Immunology
• Genetics
• Hematology

Context:

• Common variable immune deficiency (CVID) is the most prevalent primary immunodeficiency.
• It is characterized by impaired B lymphocyte differentiation and hypogammaglobulinemia.
• Clinical features include recurrent infections, autoimmunity, and increased cancer risk.

Purpose:

• To summarize current understanding of CVID.
• To highlight recent advances in genetic mechanisms.
• To emphasize the importance of early diagnosis and treatment.

Summary:

• CVID involves B cell defects leading to low immunoglobulin levels.
• Manifestations range from infections to autoimmune conditions and malignancies.
• Genetic insights are emerging, and immunoglobulin replacement therapy is the standard treatment.

Impact:

• Intravenous immunoglobulin therapy significantly improves patient survival and quality of life.
• Further research into pathophysiology and early detection is crucial.
• Delayed diagnosis negatively impacts morbidity and mortality rates.